LASSBio-1911
LASSBio-1911 is a potent and selective HDAC6 inhibitor with demonstrated antitumor activity against hepatocellular carcinoma (HCC) cell lines in vitro, showing preferential cytotoxicity towards cancer cells over normal cells, making it a candidate for oncology research.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog